These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12151869)

  • 1. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.
    Engeli S; Sharma AM
    Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of obesity hypertension.
    Hall JE
    Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that influence the risk of hypertension in obese individuals.
    Coatmellec-Taglioni G; Ribière C
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin and hypertension in obesity.
    Bravo PE; Morse S; Borne DM; Aguilar EA; Reisin E
    Vasc Health Risk Manag; 2006; 2(2):163-9. PubMed ID: 17319461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity.
    Hall JE
    Hypertension; 1994 Mar; 23(3):381-94. PubMed ID: 8125566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and treatment of obesity hypertension.
    Wofford MR; Hall JE
    Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kidney, hypertension, and obesity.
    Hall JE
    Hypertension; 2003 Mar; 41(3 Pt 2):625-33. PubMed ID: 12623970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adipose tissue for cardiovascular-renal regulation in health and disease.
    Engeli S; Sharma AM
    Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
    Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
    Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and obesity.
    Aneja A; El-Atat F; McFarlane SI; Sowers JR
    Recent Prog Horm Res; 2004; 59():169-205. PubMed ID: 14749502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
    Kalil GZ; Haynes WG
    Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension in obese patients: Pathophysiology and management].
    Girerd X; Hansel B
    Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the obesity epidemic on hypertension and renal disease.
    Hall JE; Jones DW; Kuo JJ; da Silva A; Tallam LS; Liu J
    Curr Hypertens Rep; 2003 Oct; 5(5):386-92. PubMed ID: 12948431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and hypertension.
    El-Atat F; Aneja A; Mcfarlane S; Sowers J
    Endocrinol Metab Clin North Am; 2003 Dec; 32(4):823-54. PubMed ID: 14711064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.
    Balasubramanian P; Hall D; Subramanian M
    Geroscience; 2019 Feb; 41(1):13-24. PubMed ID: 30519806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sympathetic nervous system in obesity hypertension.
    Lohmeier TE; Iliescu R
    Curr Hypertens Rep; 2013 Aug; 15(4):409-16. PubMed ID: 23677623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
    Landsberg L
    J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity hypertension: role of leptin and sympathetic nervous system.
    Hall JE; Hildebrandt DA; Kuo J
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):103S-115S. PubMed ID: 11411745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.